Quality standard measure: Proportion of adults with non‑valvular atrial fibrillation and a CHA2DS2‑VASC stroke risk score of 2 or above who receive anticoagulation.
What was measured: AF007: In those patients with atrial fibrillation with a record of a CHA2DS2-VASc score of 2 or more, the percentage of patients who are currently treated with anti-coagulation drug therapy.
Data collection end: March 2016
Data collection end: March 2017
Data collection end: March 2019
||Health and Social Care Information Centre. Quality and Outcomes Framework.